Handelsbanken Fonder’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Handelsbanken Fonder’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-680,000	Closed	-$2.55M	–	196
2019 Q1	$2.55M	Buy	680,000 +40,000	+6%	+$150K	0.05%	164
2018 Q4	$2.3M	Hold	640,000	–	–	0.05%	156
2018 Q3	$3.67M	Buy	640,000 +250,000	+64%	+$1.43M	0.07%	155
2018 Q2	$1.95M	Buy	390,000 +25,500	+7%	+$131K	0.04%	172
2018 Q1	$1.87M	Buy	364,500 +94,500	+35%	+$569K	0.04%	170
2017 Q4	$1.62M	Buy	270,000 +100,000	+59%	+$602K	0.04%	160
2017 Q3	$944K	Buy	+170,000	New	+$878K	0.02%	166

Other funds holding FOMX

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Handelsbanken Fonder's FOMX Position: Q2 2019 in Review

Handelsbanken Fonder sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2019, closing a stake of 680,000 shares — an estimated $2.55M sold.

Handelsbanken Fonder first reported a position in FOMX in Q3 2017 and held it in 7 quarters. The position peaked at $3.67M in Q3 2018. 58 funds tracked by Wall St. Rank hold FOMX as of Q2 2019.

Handelsbanken Fonder reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2019 after selling out during the quarter.
Handelsbanken Fonder sold 680,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2019, an estimated $2.55M.
Handelsbanken Fonder first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2017 and held it in 7 quarters.
Handelsbanken Fonder's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $3.67M in Q3 2018.
58 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2019.

Based on Handelsbanken Fonder's 13F filing for Q2 2019, filed 12 Jul 2019.